Researchers at UC San Diego and other institutions Tuesday found that private health insurers that sponsor Medicare Part D are artificially inflating the costs of certain generic drugs by overpaying pharmacies.
Researchers at UC San Diego and other institutions Tuesday found that private health insurers that sponsor Medicare Part D are artificially inflating the costs of certain generic drugs by overpaying pharmacies.
